Heo Jeonghoon, Factor Valentina M, Uren Tania, Takahama Yasushi, Lee Ju-Seog, Major Marian, Feinstone Stephen M, Thorgeirsson Snorri S
Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD 20892, USA.
Hepatology. 2006 Dec;44(6):1478-86. doi: 10.1002/hep.21441.
We established an efficient system for differentiation, expansion and isolation of hepatic progenitor cells from mouse embryonic stem (ES) cells and evaluated their capacity to repopulate injured liver. Using mouse ES cells transfected with the green fluorescent protein (GFP) reporter gene regulated by albumin (ALB) enhancer/promoter, we found that a serum-free chemically defined medium supports formation of embryoid bodies (EBs) and differentiation of hepatic lineage cells in the absence of exogenous growth factors or feeder cell layers. The first GFP+ cells expressing ALB were detected in close proximity to "beating" myocytes after 7 days of EB cultures. GFP+ cells increased in number, acquired hepatocyte-like morphology and hepatocyte-specific markers (i.e., ALB, AAT, TO, and G6P), and by 28 days represented more than 30% of cells isolated from EB outgrowths. The FACS-purified GFP+ cells developed into functional hepatocytes without evidence of cell fusion and participated in the repairing of diseased liver when transplanted into MUP-uPA/SCID mice. The ES cell-derived hepatocytes were responsive to normal growth regulation and proliferated at the same rate as the host hepatocytes after an additional growth stimulus from CCl(4)-induced liver injury. The transplanted GFP+ cells also differentiated into biliary epithelial cells. In conclusion, a highly enriched population of committed hepatocyte precursors can be generated from ES cells in vitro for effective cell replacement therapy.
我们建立了一个高效的系统,用于从小鼠胚胎干细胞(ES细胞)中分化、扩增和分离肝祖细胞,并评估它们在受损肝脏中重新填充的能力。利用转染了由白蛋白(ALB)增强子/启动子调控的绿色荧光蛋白(GFP)报告基因的小鼠ES细胞,我们发现无血清化学限定培养基在无外源性生长因子或饲养层细胞的情况下支持胚状体(EBs)的形成和肝系细胞的分化。在EB培养7天后,首次在靠近“跳动”的心肌细胞处检测到表达ALB的GFP+细胞。GFP+细胞数量增加,获得肝细胞样形态和肝细胞特异性标志物(即ALB、AAT、TO和G6P),到28天时,占从EB生长物中分离细胞的30%以上。经荧光激活细胞分选(FACS)纯化的GFP+细胞发育成功能性肝细胞,无细胞融合迹象,当移植到MUP-uPA/SCID小鼠体内时参与患病肝脏的修复。ES细胞来源的肝细胞对正常生长调节有反应,在四氯化碳(CCl₄)诱导的肝损伤给予额外生长刺激后,其增殖速度与宿主肝细胞相同。移植的GFP+细胞也分化为胆管上皮细胞。总之,体外可从ES细胞产生高度富集的定向肝细胞前体细胞群体,用于有效的细胞替代治疗。